Shaw Christi 4
4 · Kyverna Therapeutics, Inc. · Filed Jan 14, 2026
Insider Transaction Report
Form 4
Shaw Christi
DirectorExecutive Chairperson
Transactions
- Award
Common Stock
[F1]2026-01-12+30,000→ 46,634 total - Award
Common Stock
[F2]2026-01-12+24,301→ 70,935 total - Award
Stock Option (right to buy)
[F3]2026-01-12+185,000→ 185,000 totalExercise: $8.23Exp: 2036-01-11→ Common Stock (185,000 underlying)
Footnotes (3)
- [F1]Represents a restricted stock unit award of common stock, 1/4th of the shares subject to which shall vest on January 12, 2027, and 1/4th of the shares subject to the restricted stock unit award shall vest following each one-year period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.
- [F2]Represents a performance restricted stock unit award of common stock, which will vest upon the Issuer's common stock achieving certain specified prices per share.
- [F3]1/4th of the shares subject to the option shall vest on January 12, 2027, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.
Signature
By: /s/ Samantha Eldredge, as Attorney-in-Fact|2026-01-14